An Overview of Randomised Studies Comparing 5-HT 3 Receptor Antagonists to Conventional Anti-emetics in the Prophylaxis of Acute Chemotherapy-induced Vomiting

Author： Jantunen I.T.   Kataja V.V.   Muhonen T.T.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.1, 1997-01, pp. : 67-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

By Jordan K.   Hinke A.   Grothey A.   Voigt W.   Arnold D.   Wolf H.-H.   Schmoll H.-J.  

Supportive Care in Cancer, Vol. 15, Iss. 9, 2007-09 ,pp. : 1023-1033

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of 5-HT 3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review

By Tramer M.R.   Reynolds D.J.M.   Stoner N.S.   Moore R.A.   McQuay H.J.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1836-1844

Elsevier

Access to resources Recommend Favorite

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

By Fasching P.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1079-1086

Springer Publishing Company

Access to resources Recommend Favorite

5-HT 3 Receptor Antagonists: Differences and Similarities

By Roila F.   Ballatori E.   Tonato M.   Del Favero A.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1364-1370

Elsevier

Access to resources Recommend Favorite

Factors influencing the choice of 5-HT 3 -receptor antagonist antiemetics: focus on elderly cancer patients

By Gridelli Cesare  

Supportive Care in Cancer, Vol. 12, Iss. 7, 2004-07 ,pp. : 487-496

Springer Publishing Company

Access to resources Recommend Favorite